{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:45:16Z","timestamp":1793825116507,"version":"4.6.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203224\/Z\/16\/Z"],"award-info":[{"award-number":["203224\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["095541\/A\/11\/Z"],"award-info":[{"award-number":["095541\/A\/11\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203224\/Z\/16\/Z"],"award-info":[{"award-number":["203224\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007172"],"award-info":[{"award-number":["T32 AI007172"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI073755"],"award-info":[{"award-number":["R01 AI073755"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI127828"],"award-info":[{"award-number":["R01 AI127828"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD091218"],"award-info":[{"award-number":["R01 HD091218"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Department of Health and Social Care","id":[{"id":"https:\/\/ror.org\/03sbpja79","id-type":"ROR","asserted-by":"crossref"}]},{"name":"French Government\u2019s Investissement d\u2019Avenir Programme (Labex Integrative Biology of Emerging Infectious Diseases, IBEID, grant ANR-10-LABX-62-IBEID 4E AAP"},{"name":"MRC-Newton fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1038\/s41590-019-0477-z","type":"journal-article","created":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T14:11:06Z","timestamp":1567433466000},"page":"1291-1298","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":107,"title":["A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection"],"prefix":"10.1038","volume":"20","author":[{"given":"Jose Luis","family":"Slon-Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwisa","family":"Dejnirattisai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett W.","family":"Jagger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7932-2341","authenticated-orcid":false,"given":"C\u00e9sar","family":"L\u00f3pez-Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiyada","family":"Wongwiwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorellin A.","family":"Durnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma S.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-1696","authenticated-orcid":false,"given":"Arturo","family":"Reyes-Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8791-3165","authenticated-orcid":false,"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3416-9480","authenticated-orcid":false,"given":"Juthathip","family":"Mongkolsapaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3549-4309","authenticated-orcid":false,"given":"Gavin R.","family":"Screaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,2]]},"reference":[{"key":"477_CR1","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745\u2013748 (2010).","journal-title":"Science"},{"key":"477_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","volume":"8","author":"M Beltramello","year":"2010","unstructured":"Beltramello, M. et al. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe 8, 271\u2013283 (2010).","journal-title":"Cell Host Microbe"},{"key":"477_CR3","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.1128\/JVI.00080-06","volume":"80","author":"K Stiasny","year":"2006","unstructured":"Stiasny, K., Kiermayr, S., Holzmann, H. & Heinz, F. X. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol. 80, 9557\u20139568 (2006).","journal-title":"J. Virol."},{"key":"477_CR4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"477_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/265739a0","volume":"265","author":"SB Halstead","year":"1977","unstructured":"Halstead, S. B. & O\u2019Rourke, E. J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265, 739\u2013741 (1977).","journal-title":"Nature"},{"key":"477_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1128\/CMR.00072-15","volume":"29","author":"D Musso","year":"2016","unstructured":"Musso, D. & Gubler, D. J. Zika virus. Clinical Microbiol. Rev. 29, 487\u2013524 (2016).","journal-title":"Clinical Microbiol. Rev."},{"key":"477_CR7","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V. M. et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"477_CR8","doi-asserted-by":"publisher","first-page":"e0004636","DOI":"10.1371\/journal.pntd.0004636","volume":"10","author":"P Brasil","year":"2016","unstructured":"Brasil, P. et al. Zika virus outbreak in Rio de Janeiro, Brazil: clinical characterization, epidemiological and virological aspects. PLoS Negl. Trop. Dis. 10, e0004636 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"477_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.cell.2016.05.008","volume":"165","author":"JJ Miner","year":"2016","unstructured":"Miner, J. J. et al. Zika virus infection during pregnancy in mice causes placental damage and fetal demise. Cell 165, 1081\u20131091 (2016).","journal-title":"Cell"},{"key":"477_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1146\/annurev-med-040717-051127","volume":"70","author":"MS Diamond","year":"2019","unstructured":"Diamond, M. S., Ledgerwood, J. E. & Pierson, T. C. Zika virus vaccine development: progress in the face of new challenges. Annu. Rev. Med. 70, 121\u2013135 (2019).","journal-title":"Annu. Rev. Med."},{"key":"477_CR11","doi-asserted-by":"publisher","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","volume":"78","author":"WD Crill","year":"2004","unstructured":"Crill, W. D. & Chang, G. J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J. Virol. 78, 13975\u201313986 (2004).","journal-title":"J. Virol."},{"key":"477_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ni.3515","volume":"17","author":"W Dejnirattisai","year":"2016","unstructured":"Dejnirattisai, W. et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol. 17, 1102\u20131108 (2016).","journal-title":"Nat. Immunol."},{"key":"477_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth, G. et al. Structural basis of potent Zika\u2013dengue virus antibody cross-neutralization. Nature 536, 48\u201353 (2016).","journal-title":"Nature"},{"key":"477_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","volume":"353","author":"K Stettler","year":"2016","unstructured":"Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823\u2013826 (2016).","journal-title":"Science"},{"key":"477_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"SV Bardina","year":"2017","unstructured":"Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175\u2013180 (2017).","journal-title":"Science"},{"key":"477_CR16","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.immuni.2019.01.005","volume":"50","author":"JA Brown","year":"2019","unstructured":"Brown, J. A. et al. Dengue virus immunity increases Zika virus-induced damage during pregnancy. Immunity 50, 751\u2013762 (2019).","journal-title":"Immunity"},{"key":"477_CR17","doi-asserted-by":"publisher","first-page":"e1006487","DOI":"10.1371\/journal.ppat.1006487","volume":"13","author":"MK McCracken","year":"2017","unstructured":"McCracken, M. K. et al. Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques. PLoS Pathog. 13, e1006487 (2017).","journal-title":"PLoS Pathog."},{"key":"477_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10901-1","volume":"7","author":"J George","year":"2017","unstructured":"George, J. et al. Prior exposure to Zika virus significantly enhances peak dengue-2 viremia in rhesus macaques. Sci. Rep. 7, 10498 (2017).","journal-title":"Sci. Rep."},{"key":"477_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15674","volume":"8","author":"P Pantoja","year":"2017","unstructured":"Pantoja, P. et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat. Commun. 8, 15674 (2017).","journal-title":"Nat. Commun."},{"key":"477_CR20","doi-asserted-by":"publisher","first-page":"e1002726","DOI":"10.1371\/journal.pmed.1002726","volume":"16","author":"A Gordon","year":"2019","unstructured":"Gordon, A. et al. Prior dengue virus infection and risk of Zika: a pediatric cohort in Nicaragua. PLoS Med. 16, e1002726 (2019).","journal-title":"PLoS Med."},{"key":"477_CR21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1126\/science.aav6618","volume":"363","author":"I Rodriguez-Barraquer","year":"2019","unstructured":"Rodriguez-Barraquer, I. et al. Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region. Science 363, 607\u2013610 (2019).","journal-title":"Science"},{"key":"477_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.15252\/embr.201745302","volume":"19","author":"FA Rey","year":"2018","unstructured":"Rey, F. A., Stiasny, K., Vaney, M. C., Dellarole, M. & Heinz, F. X. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Rep. 19, 206\u2013224 (2018).","journal-title":"EMBO Rep."},{"key":"477_CR23","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R De Alwis","year":"2012","unstructured":"De Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl Acad. Sci. USA 109, 7439\u20137444 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"477_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","volume":"166","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. Structural basis of Zika virus-specific antibody protection. Cell 166, 1016\u20131027 (2016).","journal-title":"Cell"},{"key":"477_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"477_CR26","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41591-018-0056-0","volume":"24","author":"P Abbink","year":"2018","unstructured":"Abbink, P. et al. Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys. Nat. Med. 24, 721\u2013723 (2018).","journal-title":"Nat. Med."},{"key":"477_CR27","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.3849","volume":"18","author":"E Fernandez","year":"2017","unstructured":"Fernandez, E. et al. Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection. Nat. Immunol. 18, 1261\u20131269 (2017).","journal-title":"Nat. Immunol."},{"key":"477_CR28","doi-asserted-by":"publisher","first-page":"139ra183","DOI":"10.1126\/scitranslmed.3003888","volume":"4","author":"EP Teoh","year":"2012","unstructured":"Teoh, E. P. et al. The structural basis for serotype-specific neutralization of dengue virus by a human antibody. Sci. Transl. Med. 4, 139ra183 (2012).","journal-title":"Sci. Transl. Med."},{"key":"477_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7341","volume":"6","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah, G. et al. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nat. Commun. 6, 6341 (2015).","journal-title":"Nat. Commun."},{"key":"477_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14722","volume":"8","author":"SS Hasan","year":"2017","unstructured":"Hasan, S. S. et al. A human antibody against Zika virus crosslinks the E protein to prevent infection. Nat. Commun. 8, 14722 (2017).","journal-title":"Nat. Commun."},{"key":"477_CR31","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.aaa8651","volume":"349","author":"G Fibriansah","year":"2015","unstructured":"Fibriansah, G. et al. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science 349, 88\u201391 (2015).","journal-title":"Science"},{"key":"477_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1073\/pnas.1815432116","volume":"116","author":"F Long","year":"2019","unstructured":"Long, F. et al. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope. Proc. Natl Acad. Sci. USA 116, 1591\u20131596 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"477_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cell.2017.09.002","volume":"171","author":"J Wang","year":"2017","unstructured":"Wang, J. et al. A human bi-specific antibody against Zika virus with high therapeutic potential. Cell 171, 229\u2013241 (2017).","journal-title":"Cell"},{"key":"477_CR34","doi-asserted-by":"publisher","first-page":"e00405","DOI":"10.1128\/JVI.00405-19","volume":"93","author":"MJ Bailey","year":"2019","unstructured":"Bailey, M. J. et al. Human monoclonal antibodies potently neutralize Zika virus and select for escape mutations on the lateral ridge of the envelope protein. J. Virol. 93, e00405\u2013e00419 (2019).","journal-title":"J. Virol."},{"key":"477_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15411","volume":"8","author":"A Rouvinski","year":"2017","unstructured":"Rouvinski, A. et al. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nat. Commun. 8, 15411 (2017).","journal-title":"Nat. Commun."},{"key":"477_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01097-5","volume":"7","author":"JL Slon Campos","year":"2017","unstructured":"Slon Campos, J. L. et al. Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of dengue and Zika viruses in mammalian cells. Sci. Rep. 7, 966 (2017).","journal-title":"Sci. Rep."},{"key":"477_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","volume":"1","author":"TC Pierson","year":"2007","unstructured":"Pierson, T. C. et al. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection. Cell Host Microbe 1, 135\u2013145 (2007).","journal-title":"Cell Host Microbe"},{"key":"477_CR38","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.1128\/JVI.00643-07","volume":"81","author":"T Oliphant","year":"2007","unstructured":"Oliphant, T. et al. Induction of epitope-specific neutralizing antibodies against West Nile virus. J. Virol. 81, 11828\u201311839 (2007).","journal-title":"J. Virol."},{"key":"477_CR39","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","volume":"23","author":"MH Collins","year":"2017","unstructured":"Collins, M. H. et al. Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg. Infect. Dis. 23, 773\u2013781 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"477_CR40","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.cell.2017.04.024","volume":"169","author":"DF Robbiani","year":"2017","unstructured":"Robbiani, D. F. et al. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169, 597\u2013609 (2017).","journal-title":"Cell"},{"key":"477_CR41","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1089\/jir.2006.26.804","volume":"26","author":"KC Sheehan","year":"2006","unstructured":"Sheehan, K. C. et al. Blocking monoclonal antibodies specific for mouse IFN-\u03b1\/\u03b2 receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 26, 804\u2013819 (2006).","journal-title":"J. Interferon Cytokine Res."},{"key":"477_CR42","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature20564","volume":"540","author":"G Sapparapu","year":"2016","unstructured":"Sapparapu, G. et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature 540, 443\u2013447 (2016).","journal-title":"Nature"},{"key":"477_CR43","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.1128\/JVI.00581-16","volume":"90","author":"MJ Gorman","year":"2016","unstructured":"Gorman, M. J., Poddar, S., Farzan, M. & Diamond, M. S. The interferon-stimulated gene Ifitm3 restricts West Nile virus infection and pathogenesis. J. Virol. 90, 8212\u20138225 (2016).","journal-title":"J. Virol."},{"key":"477_CR44","first-page":"77","volume":"83","author":"JG Frierson","year":"2010","unstructured":"Frierson, J. G. The yellow fever vaccine: a history. Yale J. Biol. Med. 83, 77\u201385 (2010).","journal-title":"Yale J. Biol. Med."},{"key":"477_CR45","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.clinthera.2017.07.001","volume":"39","author":"MH Collins","year":"2017","unstructured":"Collins, M. H. & Metz, S. W. Progress and works in progress: update on flavivirus vaccine development. Clin. Ther. 39, 1519\u20131536 (2017).","journal-title":"Clin. Ther."},{"key":"477_CR46","doi-asserted-by":"publisher","first-page":"e0003749","DOI":"10.1371\/journal.pntd.0003749","volume":"9","author":"J Flipse","year":"2015","unstructured":"Flipse, J. & Smit, J. M. The complexity of a dengue vaccine: a review of the human antibody response. PLoS Negl. Trop. Dis. 9, e0003749 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"477_CR47","doi-asserted-by":"publisher","first-page":"e00036-17","DOI":"10.1128\/CVI.00036-17","volume":"24","author":"SL Keasey","year":"2017","unstructured":"Keasey, S. L. et al. Antibody responses to Zika virus infections in environments of flavivirus endemicity. Clin. Vaccine Immunol. 24, e00036-17 (2017).","journal-title":"Clin. Vaccine Immunol."},{"key":"477_CR48","doi-asserted-by":"publisher","first-page":"e1007640","DOI":"10.1371\/journal.ppat.1007640","volume":"15","author":"T Langerak","year":"2019","unstructured":"Langerak, T. et al. The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis. PLoS Pathog. 15, e1007640 (2019).","journal-title":"PLoS Pathog."},{"key":"477_CR49","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114\u20131125 (2017).","journal-title":"Cell"},{"key":"477_CR50","doi-asserted-by":"publisher","first-page":"e96700","DOI":"10.1371\/journal.pone.0096700","volume":"9","author":"G Petris","year":"2014","unstructured":"Petris, G., Bestagno, M., Arnoldi, F. & Burrone, O. R. New tags for recombinant protein detection and O-glycosylation reporters. PLoS ONE 9, e96700 (2014).","journal-title":"PLoS ONE"},{"key":"477_CR51","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.chom.2018.04.003","volume":"23","author":"MJ Gorman","year":"2018","unstructured":"Gorman, M. J. et al. An immunocompetent mouse model of Zika virus infection. Cell Host Microbe 23, 672\u2013685 (2018).","journal-title":"Cell Host Microbe"},{"key":"477_CR52","doi-asserted-by":"publisher","first-page":"E322","DOI":"10.3390\/v11040322","volume":"11","author":"C Lopez-Camacho","year":"2019","unstructured":"Lopez-Camacho, C. et al. Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against chikungunya virus. Viruses 11, E322 (2019).","journal-title":"Viruses"},{"key":"477_CR53","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-019-0477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-019-0477-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-019-0477-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:46:59Z","timestamp":1733939219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-019-0477-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,2]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["477"],"URL":"https:\/\/doi.org\/10.1038\/s41590-019-0477-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736535455.793568049","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,2]]},"assertion":[{"value":"6 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.R.S., F.A.R. and J.M. are named inventors on a patent owned by Imperial College London and Institut Pasteur describing the EDE and its use as a potential immunogen (application number EP3172229A1). G.R.S. sits on the advisory board of GSK Vaccines. M.S.D. is a consultant for Inbios and Atreca, and sits on the Scientific Advisory Board at Moderna. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}